期刊文献+

格列美脲治疗2型糖尿病的疗效与药理分析 被引量:6

下载PDF
导出
摘要 目的:探讨2型糖尿病患者应用格列美脲治疗的疗效并分析药理作用。方法:选择本院2013年9月-2014年11月收治的101例2型糖尿病患者的临床资料进行分析,根据患者住院尾号的奇偶数分组,A组(52例)与B组(49例),给予B组患者格列齐特治疗,给予A组患者格列美脲治疗。结果:A组患者空腹血糖(FPG)、糖化血红蛋白(Hb A1c)以及餐后2 h血糖(2 h PG)等指标均低于B组(P<0.05);A组高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、总胆固醇(TC)以及三酰甘油(TG)等指标改善情况均优于B组(P<0.05)。结论:应用格列美脲治疗2型糖尿病,可明显提高治疗有效率,改善血糖指标。
机构地区 云阳县人民医院
出处 《深圳中西医结合杂志》 2016年第10期87-89,共3页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献8

二级参考文献54

  • 1周建辉,陈香美,谢院生,吴杰,陆菊明,潘长玉.糖尿病肾病不同程度蛋白尿的相关因素分析及随访[J].中华肾脏病杂志,2005,21(5):251-255. 被引量:58
  • 2沈健,许惠琴,刘洪,韦敏.黄芪注射液对AGEs培养肾小球系膜细胞的影响[J].中成药,2006,28(8):1170-1174. 被引量:13
  • 3Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12) : 1090-1101.
  • 4Neumiller J J, Wood L, Campbell RK. Dipeptidyl pep- tidase4 inhibitors for the treatment of type 2 diabetes mellitus[ J ]. Pharmacotherapy, 2010, 30 (5) : 463- 484.
  • 5Krishna R, Herman G, Wagner JA. Accelerating drug development using biomarkers: a case study with sita- gliptin, a novel DPP4 inhibitor for type 2 diabetes [ J ]. AAPS J, 2008, 10(2) : 401-409.
  • 6Heise T, Graefe-Mody EU, Huttner S, et al. Pharma- cokinetics, pharmacodynamics and tolerability of mul- tiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients [ J ]. Diabetes Obes Metab, 2009, 11(8): 786-794.
  • 7Bajaj M, Gilman R, Patel S, et al. Linagliptin im- proved glycaemic control without weight gain or hypo- glycaemia in patients with type 2 diabetes inadequately controlled by a combination of mefformin and pioglita- zone : a 24-week randomized, double-blind study [ J ]. Diabet Med, 2014, 31(12) : 1505-1514.
  • 8Barnett AH, Patel S, Harper R, et al. Linagliptin monotherapy in type 2 diabetes patients for whom met- formin is inappropriate : an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension [ J ]. Diabetes Obes Metab, 2012, 14(12) : 1145-1154.
  • 9Barnett AH, Huisman H, Jones R, et al. Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-con- trolled trial [ J ]. Lancet, 2013, 382 ( 9902 ) : 1413- 1423.
  • 10Del PS, Barnett AH, Huisman H, et al. Effect of lin- agliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately con- trolled type 2 diabetes: a randomized controlled trial [J]. Diabetes Obes Metab, 2011, 13(3) : 258-267.

共引文献80

同被引文献29

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部